Simon Evans
Finanzdirektor/CFO bei National Pharma Services
Aktive Positionen von Simon Evans
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
National Pharma Services
National Pharma Services Pharmaceuticals: MajorHealth Technology National Pharma Services provides pharmaceutical services. Martin Riley has been the CEO of the British company since 2005. | Finanzdirektor/CFO | 03.09.2010 | - |
Karriereverlauf von Simon Evans
Ehemalige bekannte Positionen von Simon Evans
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
DECHRA PHARMACEUTICALS | Direktor/Vorstandsmitglied | 01.01.1997 | 19.10.2012 |
Finanzdirektor/CFO | 01.01.1997 | 19.10.2012 |
Statistik
International
Vereinigtes Königreich | 3 |
Operativ
Director of Finance/CFO | 2 |
Director/Board Member | 1 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Dechra Pharmaceuticals Plc
Dechra Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Dechra Pharmaceuticals Ltd. is a holding company, which engages in the veterinary pharmaceuticals and related products business. It operates through the following segments: European Pharmaceuticals; North American Pharmaceuticals; and Pharmaceuticals Research and Development. The European Pharmaceuticals segment markets and sells licensed pharmaceuticals and specialist pet foods to the veterinary profession in Europe. The North American Pharmaceuticals segment focuses on the sale of a range of endocrine, ophthalmic, dermatological, and equine products in North America. The Pharmaceuticals Research and Development segment develops and licenses Dechra's own branded veterinary product portfolio of novel and generic pharmaceuticals and specialist pet diets. The company was founded in 1819 and is headquartered in Northwich, the United Kingdom. | Health Technology |
National Pharma Services
National Pharma Services Pharmaceuticals: MajorHealth Technology National Pharma Services provides pharmaceutical services. Martin Riley has been the CEO of the British company since 2005. | Health Technology |
- Börse
- Insiders
- Simon Evans
- Erfahrung